Intervention Review

You have free access to this content

Rifabutin for treating pulmonary tuberculosis

  1. Geraint R Davies1,*,
  2. Stefania Cerri2,
  3. Luca Richeldi2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 5 JUL 2007

DOI: 10.1002/14651858.CD005159.pub2

Database Title

Additional Information

How to Cite

Davies GR, Cerri S, Richeldi L. Rifabutin for treating pulmonary tuberculosis. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD005159. DOI: 10.1002/14651858.CD005159.pub2.

Author Information

  1. 1

    University of Liverpool, School of Clinical Sciences, Liverpool, Merseyside, UK

  2. 2

    Policlinico di Modena, Universita di Modena e Reggio Emilia, Divisione di Pneumologia, Modena, Italy

*Geraint R Davies, School of Clinical Sciences, University of Liverpool, Royal Liverpool University Hospital, Prescot Street, Liverpool, Merseyside, L7 8XP, UK. gerrydavies@doctors.org.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (219K)Full (269K)
[Analysis 1.1]
Analysis 1.1. Comparison 1 Rifabutin vs rifampicin, Outcome 1 Cure.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Rifabutin vs rifampicin, Outcome 2 Relapse.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Rifabutin vs rifampicin, Outcome 3 M. tuberculosis culture status 2 months after starting therapy.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Rifabutin vs rifampicin, Outcome 4 M. tuberculosis culture status 3 months after starting therapy.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Rifabutin vs rifampicin, Outcome 5 Adverse events.
View Full Article (HTML) Summary (59K)Standard (219K)Full (269K)